(2R,3R,4R,5S,6R)-3,4,5-trihydroxy-6-{[(2S)-3-phenyl-2-{[(1r,4r)-4-(propan-2-yl)cyclohexyl]formamido}propanoyl]oxy}oxane-2-carboxylic acid

• ChemBase编号: 175027
• 分子式: C25H35NO9
• 平均质量: 493.5467
• 单一同位素质量: 493.23118171
• SMILES: C([C@H](NC(=O)[C@@H]1CC[C@H](CC1)C(C)C)C(=O)O[C@H]1O[C@@H]([C@@H]([C@H]([C@H]1O)O)O)C(=O)O)c1ccccc1
• Canonical SMILES: CC([C@@H]1CC[C@H](CC1)C(=O)N[C@H](C(=O)O[C@H]1O[C@H](C(=O)O)[C@@H]([C@H]([C@H]1O)O)O)Cc1ccccc1)C
• InChI: InChI=1S/C25H35NO9/c1-13(2)15-8-10-16(11-9-15)22(30)26-17(12-14-6-4-3-5-7-14)24(33)35-25-20(29)18(27)19(28)21(34-25)23(31)32/h3-7,13,15-21,25,27-29H,8-12H2,1-2H3,(H,26,30)(H,31,32)/t15-,16-,17-,18+,19+,20-,21+,25+/m0/s1
• InChIKey: YTIRWNSTJVSCRW-GUJLTLOXSA-N

名称和登记号

名称

• IUPAC标准名: (2R,3R,4R,5S,6R)-3,4,5-trihydroxy-6-{[(2S)-3-phenyl-2-{[(1r,4r)-4-(propan-2-yl)cyclohexyl]formamido}propanoyl]oxy}oxane-2-carboxylic acid
• IUPAC传统名: (2R,3R,4R,5S,6R)-3,4,5-trihydroxy-6-{[(2S)-3-phenyl-2-{[(1r,4r)-4-isopropylcyclohexyl]formamido}propanoyl]oxy}oxane-2-carboxylic acid
• 别名: N-[[trans-4-(1-Methylethyl)cyclohexyl]carbonyl]-L-phenylalanine β-D-Glucopyranuronic Acid; L-Nateglinide Acyl Glucuronide; ent-Nateglinide Acyl-β-D-glucuronide

登记号

• CAS号: 1357003-01-0
• PubChem SID: 164230937
• PubChem CID: 71750956

理论计算性质

• Acid pKa: 3.171759
• 质子受体: 8
• 质子供体: 5
• LogD (pH = 5.5): -0.2231105
• LogD (pH = 7.4): -1.3695333
• Log P: 2.0807772
• 摩尔折射率: 121.7591 cm^3
• 极化性: 49.041466 Å^3
• 极化表面积: 162.62 Å^2
• 可自由旋转的化学键: 9
• 里宾斯基五规则: true

详细说明

Toronto Research Chemicals - N379385

Potential metabolite of Nateglinide impurity, a novel D-phenylalanine-derivative hypoglycemic agent.